Published in Heart Lung on December 18, 2002
Correlations between gait speed, 6-minute walk distance, physical activity, and self-efficacy in patients with severe chronic lung disease. Respir Care (2013) 0.94
Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? A chart review. Prim Care Companion J Clin Psychiatry (2005) 0.91
Multivariate models of determinants of health-related quality of life in severe chronic obstructive pulmonary disease. J Rehabil Res Dev (2009) 0.87
Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.84
Home-based pulmonary rehabilitation program: Effect on exercise tolerance and quality of life in chronic obstructive pulmonary disease patients. Ann Thorac Med (2010) 0.81
Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study). BMC Pulm Med (2016) 0.78
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol (2012) 7.39
Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest (2002) 3.82
Association between sleep apnea, sleep duration, and serum lipid profile in an urban, male, working population in Japan. Chest (2013) 3.23
COPD in Japan: the Nippon COPD Epidemiology study. Respirology (2004) 2.81
Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med (2002) 2.41
Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med (2003) 2.32
A randomized, placebo-controlled trial of acupuncture in patients with chronic obstructive pulmonary disease (COPD): the COPD-acupuncture trial (CAT). Arch Intern Med (2012) 2.20
Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 2.03
Quantitative assessment of airway remodeling using high-resolution CT. Chest (2002) 1.79
Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest (2004) 1.77
Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest (2007) 1.66
CT scan findings of emphysema predict mortality in COPD. Chest (2010) 1.57
Effect of short-term treatment with inhaled corticosteroid on airway wall thickening in asthma. Am J Med (2004) 1.53
Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med (2005) 1.52
Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med (2005) 1.52
Specific IgE response to trichophyton and asthma severity. Chest (2009) 1.49
Hot spring bath and Legionella pneumonia: an association confirmed by genomic identification. Intern Med (2002) 1.48
Corrected QT dispersion and cardiac sympathetic function in patients with obstructive sleep apnea-hypopnea syndrome. Chest (2004) 1.47
Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment. J Hypertens (2006) 1.46
Diabetes insipidus from neurosarcoidosis: long-term follow-up for more than eight years. Intern Med (2004) 1.46
Importance of ventilator mode in long-term noninvasive positive pressure ventilation. Respir Med (2009) 1.43
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer. Cancer Chemother Pharmacol (2012) 1.43
Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration (2005) 1.42
Videothoracoscopy-assisted surgical lung biopsy for interstitial lung diseases. Gen Thorac Cardiovasc Surg (2014) 1.41
Noninvasive ventilation improves the outcome of pulmonary complications after liver resection. Intern Med (2010) 1.40
Pulmonary hemorrhage induced by epileptic seizure. Heart Lung (2011) 1.39
Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancer. J Thorac Oncol (2010) 1.34
Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology (2008) 1.32
Treatment of pulmonary epithelioid hemangioendothelioma with bevacizumab. J Thorac Oncol (2010) 1.32
Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest (2008) 1.28
Prostaglandin F(2alpha) receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-beta. Nat Med (2009) 1.28
Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med (2004) 1.27
Good clinical response to gefitinib in a non-small cell lung cancer patient harboring a rare somatic epidermal growth factor gene point mutation; codon 768 AGC > ATC in exon 20 (S768I). Jpn J Clin Oncol (2010) 1.26
Abnormal swallowing reflex and COPD exacerbations. Chest (2009) 1.22
Surveillance of pathogens in outpatients with gastroenteritis and characterization of sapovirus strains between 2002 and 2007 in Kumamoto Prefecture, Japan. J Med Virol (2009) 1.18
Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med (2006) 1.18
Role of non-invasive ventilation in managing life-threatening acute exacerbation of interstitial pneumonia. Intern Med (2010) 1.16
Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer. Lung Cancer (2008) 1.14
Optimal cutoff level of breath carbon monoxide for assessing smoking status in patients with asthma and COPD. Chest (2003) 1.11
Reversed halo sign in pneumocystis pneumonia: a case report. BMC Med Imaging (2010) 1.11
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation. Cancer Chemother Pharmacol (2011) 1.11
Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest (2006) 1.10
The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. Am J Pathol (2004) 1.08
Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma. Cancer (2010) 1.07
Maintenance Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor after First-Line Chemotherapy in Mutation-Positive Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 1.07
Role of small airways in asthma: investigation using high-resolution computed tomography. J Allergy Clin Immunol (2006) 1.07
Isolation of drug-resistant pathogens does not always require use of broad-spectrum antibiotics in pneumonia. Am J Respir Crit Care Med (2014) 1.06
Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. J Immunol (2007) 1.05
Natural Japanese encephalitis virus infection among humans in west and east Japan shows the need to continue a vaccination program. Vaccine (2010) 1.05
All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med (2006) 1.05
Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice. J Pharmacol Exp Ther (2008) 1.04
Longitudinal study of airway dimensions in chronic obstructive pulmonary disease using computed tomography. Respirology (2008) 1.04
Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. Pulm Pharmacol Ther (2009) 1.01
Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease. Respir Res (2012) 1.01
Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment. Respirology (2008) 1.00
Cyclophosphamide-induced late-onset lung disease. Intern Med (2003) 1.00
Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer. Cancer Sci (2009) 1.00
COPD and disease-specific health status in a working population. Respir Res (2013) 1.00
Differentiation between Birt-Hogg-Dubé syndrome and lymphangioleiomyomatosis: quantitative analysis of pulmonary cysts on computed tomography of the chest in 66 females. Eur J Radiol (2011) 1.00
Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med (2003) 1.00
Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med (2011) 1.00
Pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer and chronic renal failure who are undergoing hemodialysis. J Thorac Oncol (2010) 0.99
Morphological mechanism of the development of pulmonary emphysema in klotho mice. Proc Natl Acad Sci U S A (2007) 0.99
Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest (2005) 0.98
The prognostic value of HRCT in myositis-associated interstitial lung disease. Respir Med (2013) 0.98
Should Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Be Continued beyond Progressive Disease? Case Rep Oncol (2011) 0.98
Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: a case report and review of the literature. Lung Cancer (2012) 0.98
Relevance of platinum sensitivity in patients with relapsed or refractory small-cell lung cancer. J Thorac Oncol (2015) 0.98
Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surg (2003) 0.98
High-dose crizotinib for brain metastases refractory to standard-dose crizotinib. J Thorac Oncol (2013) 0.98
Familial cases of psittacosis: possible person-to-person transmission. Intern Med (2002) 0.97
Airway wall thickening in patients with cough variant asthma and nonasthmatic chronic cough. Chest (2007) 0.97
All-trans retinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system. Am J Physiol Lung Cell Mol Physiol (2005) 0.97
Epidermal growth factor receptor gene mutations in papillary thyroid carcinoma. Int J Cancer (2009) 0.97
HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med (2011) 0.97
Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol (2013) 0.97
Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease. Respiration (2011) 0.96
Clinical and radiographic indices associated with airflow limitation in patients with sarcoidosis. Chest (2006) 0.96
TGFB1 promoter polymorphism C-509T and pathophysiology of asthma. J Allergy Clin Immunol (2007) 0.95
Phase II study of carboplatin and pemetrexed in advanced non-squamous, non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0902. Cancer Chemother Pharmacol (2012) 0.94
Retrospective case series analysing the clinical data and treatment options of patients with a tubercular abscess of the chest wall. Interact Cardiovasc Thorac Surg (2011) 0.94
Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma. Am J Respir Crit Care Med (2014) 0.93
Sarcoidosis with bilateral epididymal and testicular lesions. Intern Med (2003) 0.93
Bronchial dilatation in asthma: relation to clinical and sputum indices. Chest (2004) 0.93
Hypersensitivity pneumonitis associated with inhalation of catechin-rich green tea extracts. Respiration (2011) 0.93
Comparison of airway dimensions in different anatomic locations on chest CT in patients with COPD. Respirology (2006) 0.93